He, Leicheng. “SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits”. Highlights in Science, Engineering and Technology, vol. 74, Dec. 2023, pp. 1717-22, https://doi.org/10.54097/m9vm2798.